Launch Delayed as FDA Red Flags Emergency Use Authorisation of Bharat Biotech’s Covaxin: Report

The phase 3 data is crucial for the company, as only with those results can the company seek emergency approval from the World Health Organisation.

Similar Articles

Advertismentspot_img

Most Popular